Therapeutic efficacy of monthly subcutaneous injection of daclizumab in relapsing multiple sclerosis
Stanley Cohan1,2,3 1Providence Multiple Sclerosis Center, 2Providence Brain and Spine Institute, 3Providence Health & Services, Portland, OR, USA Abstract: Despite the availability of multiple disease-modifying therapies for relapsing multiple sclerosis (MS), there remains a need for highly...
Saved in:
| Main Author: | |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Dove Medical Press
2016
|
| Subjects: | |
| Online Access: | https://doaj.org/article/a2a044b93820402db845b0bff30c7a2d |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|